Analystreport

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report